Vigil Neuroscience — Company Overview, News & Financial Data

Vigil Neuroscience (NASDAQ:VIGL) is dedicated to tackling neurodegenerative diseases by understanding and leveraging the power of microglia, the brain's primary immune cells. Their focused approach aims to develop treatments that can modify disease progression in conditions such as Alzheimer's and Amyotrophic Lateral Sclerosis (ALS). With a deep commitment to innovation, Vigil Neuroscience embarks on projects that explore the potential of microglial restoration and protection. The company's objective is to bring forth novel therapies that can significantly improve the lives of patients suffering from these debilitating diseases, providing hope through scientific advancement and dedicated research.